openPR Logo
Press release

Benin Prostatic Hyperplasis Devices Industry Forecast to 2027 - Lumenis, Boston Scientific Corporation, NeoTract, Coloplast Pty, Dornier MedTech, Richard Wolf GmbH, NxThera

12-12-2018 07:12 AM CET | Health & Medicine

Press release from: The Insight Partners

The Insight Partners

The Insight Partners

A comprehensive analysis on “Benin Prostatic Hyperplasis Devices Market” is the latest industry dynamics that is inclusive of market drivers, restraints, and opportunities is part of the report. This report includes potential opportunities in the cell harvesting industry at the global and regional levels.

Global Benin Prostatic Hyperplasis Devices Market Analysis and Forecasts to 2027

The enlargement of the prostate gland is known as benign prostatic hyperplasia (BPH). The enlargement of this gland is generally seen in the baby boomers. This may cause symptom such as uncomfortable urine and can also cause bladder or kidney problems. The risk factors for the enlarged prostate glands are aging, family history, diabetes, heart disease and lifestyle.

Key players influencing the market are Karl Storz Gmbh & Co.Kg, Olympus, Lumenis, Boston Scientific Corporation, NeoTract, Inc., Coloplast Pty Ltd, Dornier MedTech., Richard Wolf GmbH, NxThera, Inc. and Convergent Laser Technologies

Get Sample Copy at https://www.theinsightpartners.com/sample/TIPMD00002609/

The "Global Benign Prostatic Hyperplasia Devices Market Analysis To 2027" is a specialized and in-depth study of the medical device industry with a focus on the benign prostatic hyperplasia devices market trend. The report aims to provide an overview of global benign prostatic hyperplasia devices market with detailed market segmentation by procedure type, end user and geography. The global benign prostatic hyperplasia devices market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading market players and offers key trends and opportunities in the Benign Prostatic Hyperplasia devices market.

The global benign prostatic hyperplasia devices market is segmented on the basis of procedure type and end user. On the basis of the procedure type the segment is classified as transurethral microwave therapy, transurethral resection of the prostate, transurethral needle ablation of the prostate, prostatic stenting, laser surgery and others. On the basis of the end user the market is segmented as hospitals & clinics, ambulatory surgical centers and others.

The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the global benign prostatic hyperplasia devices market based on product, material, end user and geography. It also provides market size and forecast till 2027 for overall benign prostatic hyperplasia devices market with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 13 counties globally along with current trend and opportunities prevailing in the region.

The Benin Prostatic Hyperplasis Devices Market report aims to provide a 360-degree view of the market in terms of cutting-edge technology, key developments, drivers, restraints and future trends with impact analysis of these trends on the market for short-term, mid-term and long-term during the forecast period. Further, the report also covers key players profiling with detailed SWOT analysis, financial facts and key developments of products/service from the past three years.

Browse Complete Report at https://www.theinsightpartners.com/reports/benin-prostatic-hyperplasis-devices-market

The Benin Prostatic Hyperplasis Devices Market report is a combination of qualitative as well as quantitative analysis which can be broken down into 40% and 60% respectively. Market estimation and forecasts are presented in the report for the overall global market from 2018 – 2027, considering 2018 as the base year and 2019 – 2027 forecast period. Global estimation is further broken down by segments and geographies such as North America, Europe, Asia-Pacific, Middle East & Africa and South America covering major 16 countries across the mentioned regions. The qualitative contents for geographical analysis will cover market trends in each region and country which includes highlights of the key players operating in the respective region/country, PEST analysis of each region which includes political, economic, social and technological factors influencing the growth of the market.

Contact Information -
Contact Person : Sameer Joshi
Phone : +1-646-491-9876
Email Id : sam@theinsightpartners.com

About Us - The Insight Partners is a one stop industry research provider of actionable intelligence. We help our clients in getting solutions to their research requirements through our syndicated and consulting research services. We are a specialist in Healthcare IT, Biotechnology and Medical Device industries.

533, 5th Floor,
Amanora Chambers, East Block, Amanora Township,
Kharadi Road, Hadapsar, Pune-411028

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Benin Prostatic Hyperplasis Devices Industry Forecast to 2027 - Lumenis, Boston Scientific Corporation, NeoTract, Coloplast Pty, Dornier MedTech, Richard Wolf GmbH, NxThera here

News-ID: 1433902 • Views:

More Releases from The Insight Partners

Vegan Bakery Ingredients Market to Grow at 8% CAGR from 2025 to 2031
Vegan Bakery Ingredients Market to Grow at 8% CAGR from 2025 to 2031
The global food landscape is undergoing a radical transformation as plant-based living moves from a niche lifestyle choice to a mainstream consumer powerhouse. Notably, the vegan bakery ingredients market has emerged as one of the most dynamic sectors within this shift. As consumers increasingly prioritize health, environmental sustainability, and animal welfare, the demand for high-quality, plant-derived alternatives to traditional baking staples has surged. According to recent analysis by The Insight
Teff Products Market to 2031: Global Industry Analysis, Growth Trends, and Forecast Insights
Teff Products Market to 2031: Global Industry Analysis, Growth Trends, and Forec …
The Teff Products Market is witnessing steady global expansion due to rising consumer awareness of gluten-free and nutrient-rich ancient grains. Teff, a traditional Ethiopian cereal grain, is increasingly being adopted in bakery items, breakfast cereals, snacks, beverages, and health-focused food products. According to The Insight Partners, the Teff Products market study provides a comprehensive outlook on growth dynamics, segmentation, and competitive landscape across the forecast period. Request Sample Pages of this
Flax Crop Market to Reach US$ 1,940.40 Million by 2034, Growing at 8.67% CAGR
Flax Crop Market to Reach US$ 1,940.40 Million by 2034, Growing at 8.67% CAGR
The flax crop market is witnessing steady growth due to increasing demand for flax seeds and flax-based products across food, textile, and industrial applications. Flax, also known as linseed, is valued for its rich content of omega-3 fatty acids, dietary fiber, and plant-based protein, making it a preferred ingredient in health-focused diets. In addition, its fibers are widely used in the textile industry for producing linen, which is gaining popularity
Albumin Market Will Generate Booming Growth Opportunities to 2031 | Key Players Research - Thermo Fisher Scientific Inc, Kedrion SpA, CSL Ltd, Biotest AG., Octapharma AG, Takeda Pharmaceutical Co Ltd, Merck etc.
Albumin Market Will Generate Booming Growth Opportunities to 2031 | Key Players …
The global albumin market is set to witness robust growth over the forecast period, driven by rising demand for plasma-derived therapies, increasing prevalence of chronic diseases, and expanding applications of albumin across clinical and pharmaceutical domains. According to a recent industry study by The Insight Partners, the albumin market is benefiting from advancements in plasma fractionation technologies and the growing emphasis on protein-based therapeutics worldwide. Download Sample PDF @ https://www.theinsightpartners.com/sample/TIPRE00003986?utm_source=OpenPR&utm_medium=10379 The albumin

All 5 Releases


More Releases for Prostatic

Rising Geriatric Population Drives Growth Of Benign Prostatic Hypertrophy Drugs …
The Drugs For Benign Prostatic hypertrophy Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories]. What Is the Projected Growth of the Drugs For Benign Prostatic hypertrophy Market? The drugs for benign prostatic hypertrophy market has shown strong growth, expanding from $4.28 billion in 2024 to $4.58
Prominent Drugs For Benign Prostatic hypertrophy Market Trend for 2025: Innovati …
What Are the Projected Growth and Market Size Trends for the Drugs For Benign Prostatic hypertrophy Market? The market size for benign prostatic hypertrophy medication has seen considerable growth in recent years. It is projected to increase from $4.28 billion in 2024 to $4.58 billion in 2025, with a compound annual growth rate (CAGR) of 6.8%. The significant growth during the historic period can be linked to an aging population, heightened
Shaping the Benign Prostatic Hyperplasia (BPH) Treatment Devices And Equipment M …
How Big Is the Benign Prostatic Hyperplasia (BPH) Treatment Devices And Equipment Market Expected to Be, and What Will Its Growth Rate Be? In recent times, there has been robust growth in the market size of benign prostatic hyperplasia (BPH) treatment devices and equipment. The market, which stood at $1.29 billion in 2024, is anticipated to increase to $1.38 billion in 2025, reflecting a compound annual growth rate (CAGR) of 7.2%.
Prominent Drugs For Benign Prostatic hypertrophy Market Trend for 2025: Innovati …
What Are the Projected Growth and Market Size Trends for the Drugs For Benign Prostatic hypertrophy Market? The market size for benign prostatic hypertrophy medication has seen considerable growth in recent years. It is projected to increase from $4.28 billion in 2024 to $4.58 billion in 2025, with a compound annual growth rate (CAGR) of 6.8%. The significant growth during the historic period can be linked to an aging population, heightened
Prominent Drugs For Benign Prostatic hypertrophy Market Trend for 2025: Innovati …
What Are the Projected Growth and Market Size Trends for the Drugs For Benign Prostatic hypertrophy Market? The market size for benign prostatic hypertrophy medication has seen considerable growth in recent years. It is projected to increase from $4.28 billion in 2024 to $4.58 billion in 2025, with a compound annual growth rate (CAGR) of 6.8%. The significant growth during the historic period can be linked to an aging population, heightened
Shaping the Benign Prostatic Hyperplasia (BPH) Treatment Devices And Equipment M …
How Big Is the Benign Prostatic Hyperplasia (BPH) Treatment Devices And Equipment Market Expected to Be, and What Will Its Growth Rate Be? In recent times, there has been robust growth in the market size of benign prostatic hyperplasia (BPH) treatment devices and equipment. The market, which stood at $1.29 billion in 2024, is anticipated to increase to $1.38 billion in 2025, reflecting a compound annual growth rate (CAGR) of 7.2%.